Verition Fund Management
DNTH icon

Verition Fund Management’s Dianthus Therapeutics DNTH Stock Holding History

Verition Fund Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
+39,503
New +$3.45M 0.02% 779
2025
Q3 		– Sell
-22,945
Closed -$427K – 3810
2025
Q2 		$427K Buy
+22,945
New +$430K ﹤0.01% 3024
2023
Q3 		– Sell
-23,642
Closed -$287K – 2421
2023
Q2 		$287K Sell
23,642
-113,762
-83% -$1.29M ﹤0.01% 1588
2023
Q1 		$1.75M Buy
+137,404
New +$1.52M 0.02% 740

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Verition Fund Management's DNTH Position: Q2 2026 in Review

Verition Fund Management opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 39,503 shares worth $3.85M. The stake represents 0.02% of the portfolio and ranks #779 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in DNTH as recently as Q2 2025.

Verition Fund Management first reported a position in DNTH in Q1 2023 and has held it in 4 quarters since. 269 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Verition Fund Management held 39,503 shares of Dianthus Therapeutics worth $3.85M as of Q2 2026.
  • Dianthus Therapeutics was a new Verition Fund Management position in Q2 2026.
  • Dianthus Therapeutics made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #779 holding.
  • Verition Fund Management first reported a position in Dianthus Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • 269 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.